Inex Medicaments Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2009.
2009 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Inex Medicaments Private Limited

Inex Medicaments Private Limited, a active private limited company, was established on 06 November 2009 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909TN2009PTC073452. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Gopalakrishnan Srinivasan (Managing Director), Banumathi Srinivasan (Director). Past directors included Ajithkumar, Prem Kumar Dhananjeyan, Obula Krishnan Muralidharan. It holds ₹2.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.22,Villa A&B, Second Floor Rajiv Street, Kamaraj Nagar, Keelkatta, Chennai, Tamil Nadu, 600117.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909TN2009PTC073452

  • Registration Number

    073452

  • Incorporation Date

    06 November 2009

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 16 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.25 Cr
  • Revenue Growth **** 4.75%
  • Profit Growth **** 3.61%
  • Ebitda **** 31.20%
  • Net Worth 15.21%
  • Total Assets **** 0.42%
Company report

Inex Medicaments Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Inex Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Inex Medicaments Private Limited?
Current Directors
Name Designation Appointment Date Status
Gopalakrishnan Srinivasan Managing Director 06 Nov 2009 Current
Banumathi Srinivasan Director 19 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 19 Mar 2025 Past
Pramod Abcsdd Director 27 Aug 2013 Past
Pramod Abcsdd Director 27 Aug 2013 Past
Pramod Abcsdd Director 27 Aug 2013 Past
Pramod Abcsdd Director 27 Aug 2013 Past
Pramod Abcsdd Director 27 Aug 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Inex Medicaments.

Inex Medicaments Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.75% increase. The company also saw a slight improvement in profitability, with a 3.61% increase in profit. The company's net worth Soared by an impressive increase of 15.21%.

Inex Medicaments revenue growth over time
Inex Medicaments profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.75%
*******
*******
*******
*******
Revenue from Operations
*******
 2.26%
*******
*******
*******
*******
Total Assets
*******
 0.42%
*******
*******
*******
*******
Profit or Loss
*******
 3.61%
*******
*******
*******
*******
Net Worth
*******
 15.21%
*******
*******
*******
*******
EBITDA
*******
 31.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Inex Medicaments?

In 2023, Inex Medicaments had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹22,450,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 2.25 Cr
Latest Charge Details
Date Lender Amount Status
13 May 2016 Others ₹2.25 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Inex Medicaments?

Unlock and access historical data on people associated with Inex Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Inex Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inex Medicaments's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Inex Medicaments
Recent Activity within the Organization
  • Annual General Meeting

    The activity Inex Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Others of Rs. 22.45 M registered on 13 May 2016 with Charge ID 100038012 was modified on 26 Aug 2025. was documented.

  • Balance Sheet

    Inex Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

  • Director Appointment

    Banumathi Srinivasan was appointed as a Director was appointed as a Director on 19 Mar 2025 & has been associated with this company since 10 months 29 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 22.45 M with Charge ID 100038012 was registered on 13 May 2016. was documented.

  • Director Appointment

    Progress on Gopalakrishnan Srinivasan was appointed as a Managing Director was appointed as a Managing Director on 06 Nov 2009 & has been associated with this company since 16 years 3 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Inex Medicaments Private Limited?

The CIN of Inex Medicaments Private Limited is U51909TN2009PTC073452.

Where is Inex Medicaments Private Limited headquartered?

Inex Medicaments Private Limited is headquartered at No.22,Villa A&B, Second Floor Rajiv Street, Kamaraj Nagar, Keelkatta, Chennai, Tamil Nadu, 600117.

When was Inex Medicaments Private Limited incorporated?

Inex Medicaments Private Limited was incorporated on 06 November 2009.

Who are the current directors of Inex Medicaments Private Limited?

The current directors of Inex Medicaments Private Limited are

What is the primary industry of Inex Medicaments Private Limited?

The primary industry of Inex Medicaments Private Limited is Trade.

Is Inex Medicaments Private Limited a listed company?

Inex Medicaments Private Limited is unlisted.

What is the capital structure of Inex Medicaments Private Limited?

The authorized capital of Inex Medicaments Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Inex Medicaments Private Limited?

The compliance status of Inex Medicaments Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available